These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25646564)

  • 1. Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.
    Mathews TP; Hill S; Rose KL; Ivanova PT; Lindsley CW; Brown HA
    ACS Chem Biol; 2015 May; 10(5):1258-68. PubMed ID: 25646564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
    Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL
    PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
    Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
    Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting phospholipase D in cancer, infection and neurodegenerative disorders.
    Brown HA; Thomas PG; Lindsley CW
    Nat Rev Drug Discov; 2017 May; 16(5):351-367. PubMed ID: 28209987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle.
    Hornberger TA; Chu WK; Mak YW; Hsiung JW; Huang SA; Chien S
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4741-6. PubMed ID: 16537399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells.
    Park MH; Min do S
    Biochem Biophys Res Commun; 2011 Sep; 412(4):710-5. PubMed ID: 21867678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of phospholipases C and D is an early response to a cold exposure in Arabidopsis suspension cells.
    Ruelland E; Cantrel C; Gawer M; Kader JC; Zachowski A
    Plant Physiol; 2002 Oct; 130(2):999-1007. PubMed ID: 12376663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.
    Han S; Huh J; Kim W; Jeong S; Min do S; Jung Y
    Exp Mol Med; 2014 Dec; 46(12):e126. PubMed ID: 25523098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous sphingosine 1-phosphate and sphingosylphosphorylcholine do not stimulate phospholipase D in C6 glioma cells.
    Dygas A; Sidorko M; Bobeszko M; Barańska J
    Acta Biochim Pol; 1999; 46(1):99-106. PubMed ID: 10453985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid.
    Kam Y; Exton JH
    FASEB J; 2004 Feb; 18(2):311-9. PubMed ID: 14769825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
    Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase D meets Wnt signaling: a new target for cancer therapy.
    Kang DW; Choi KY; Min do S
    Cancer Res; 2011 Jan; 71(2):293-7. PubMed ID: 21224347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages.
    Kusner DJ; Hall CF; Schlesinger LS
    J Exp Med; 1996 Aug; 184(2):585-95. PubMed ID: 8760812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD).
    Castellani B; Diamanti E; Pizzirani D; Tardia P; Maccesi M; Realini N; Magotti P; Garau G; Bakkum T; Rivara S; Mor M; Piomelli D
    Chem Commun (Camb); 2017 Nov; 53(95):12814-12817. PubMed ID: 29143042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and redox state are involved in epigallocatechin gallate-induced phospholipase D activation in human astroglioma cells.
    Kim SY; Ahn BH; Kim J; Bae YS; Kwak JY; Min G; Kwon TK; Chang JS; Lee YH; Yoon SH; Min DS
    Eur J Biochem; 2004 Sep; 271(17):3470-80. PubMed ID: 15317582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy.
    Williams SA; Tappia PS; Yu CH; Bibeau M; Panagia V
    J Mol Cell Cardiol; 1998 Jan; 30(1):109-18. PubMed ID: 9500869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.